488 related articles for article (PubMed ID: 20056300)
1. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy.
Pagano L; Caira M; Fianchi L
Ann Med; 2005; 37(4):259-69. PubMed ID: 16019724
[TBL] [Abstract][Full Text] [Related]
4. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
5. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
Ruhnke M; Maschmeyer G
Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of fungal infections in children and adolescents with cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
[TBL] [Abstract][Full Text] [Related]
7. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
8. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
9. Antifungal prophylaxis for invasive mycoses in high risk patients.
Ullmann AJ; Cornely OA
Curr Opin Infect Dis; 2006 Dec; 19(6):571-6. PubMed ID: 17075333
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
11. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
12. Antifungal treatment strategies in high risk patients.
Rüping MJ; Vehreschild JJ; Cornely OA
Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
[TBL] [Abstract][Full Text] [Related]
13. [Systemic fungal infections in immunocompromised patients].
Zupanić-Krmek D; Nemet D
Acta Med Croatica; 2004; 58(4):251-61. PubMed ID: 15700680
[TBL] [Abstract][Full Text] [Related]
14. Fungal respiratory disease.
Yao Z; Liao W
Curr Opin Pulm Med; 2006 May; 12(3):222-7. PubMed ID: 16582678
[TBL] [Abstract][Full Text] [Related]
15. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy.
Anaissie EJ
Best Pract Res Clin Haematol; 2008 Dec; 21(4):683-90. PubMed ID: 19041608
[TBL] [Abstract][Full Text] [Related]
17. A new era of antifungal therapy.
Wingard JR; Leather H
Biol Blood Marrow Transplant; 2004 Feb; 10(2):73-90. PubMed ID: 14750074
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
Karthaus M; Böhme A
Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
[TBL] [Abstract][Full Text] [Related]
19. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
Mullane K; Toor AA; Kalnicky C; Rodriguez T; Klein J; Stiff P
Transpl Infect Dis; 2007 Jun; 9(2):89-96. PubMed ID: 17461992
[TBL] [Abstract][Full Text] [Related]
20. Fungal infections in cancer patients: an escalating problem.
Samonis G; Bafaloukos D
In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]